Common biological pathways in eating disorders and obesity

Addictive Behaviors

Volumn 21, Issue 6, 1996, Pages 733-743

  Ericsson, Martin ^b   Poston II, Walker S Carlos ^a   Foreyt, John P ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; CATECHOLAMINE; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DOPAMINE; NEUROPEPTIDE; NEUROPEPTIDE Y; NORADRENALIN; PEPTIDE YY; SEROTONIN;

ANOREXIA; BULIMIA; FEEDING BEHAVIOR; FEEDING DISORDER; HUMAN; OBESITY; REVIEW; SEROTONINERGIC SYSTEM;

EID: 0030296187     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4603(96)00032-9     Document Type: Article

References (60)

1. Advokat, C., & Kutlesic, V. (1995). Pharmacotherapy of the eating disorders: A commentary. Neuroscience and Biobehavioral Reviews, 19, 59-66.
2. Björntorp, P. (1995). Neuroendocrine abnormalities in human obesity. Metabolism, 44(Suppl. 2), 38-41.
3. Brambilla, F., Ferrari, E., Panerai, A., Manfredi, B., Petraglia, F., Catalano, M., & Sacerdote, P. (1993a). Psychoimmunoendocrine investigation of anorexia nervosa. Neuropsychobiology, 27, 9-16.
4. Brambilla, F., Brunetta, M., Peirone, A., Manzotti, A., Sacerdote, P., & Panerai, A. E. (1993b). Lymphocyte concentrations of β-endorphin and cholecystokinin-8 in anorexia and bulimia nervosa. In E. Ferrari, F. Brambilla, & S. B. Solerte (Eds.), Primary and secondary eating disorders: A psychoneuroendocrine and metabolic approach (pp. 167-174). Oxford, UK: Pergamon Press.
5. Brambilla, F., Bellodi, L., Perna, G., Barberi, A., Panerai, A., & Sacerdote, P. (1993c). Lymphocyte cholecystokinin concentrations in panic disorder. American Journal of Psychiatry, 150, 1111-1113.
6. Brewerton, T. D. (1995). Toward a unified theory of serotonin disturbances in eating and related disorders. Psychoneuroimmunology, 20, 561-590.
7. Brewerton, T. D., Hand, L. D., & Bishop, E. R. (1993). The Tridimensional Personality Questionnaire in eating disorder patients. International Journal of Eating Disorders, 14, 213-218.
8. Brewerton, T. D., Lydiard, R. B., Laraia, M. T., Shook, J. E., & Ballenger, J. C. (1992). CSF β-endorphin and dynorphin in bulimia nervosa. American Journal of Psychiatry, 149, 1086-1090.
9. Brownell, K. D., & Wadden, T. A. (1992). Etiology and treatment of obesity: Understanding a serious, prevalent, and refractory disorder. Journal of Consulting and Clinical Psychology, 60, 505-517.
10. Brunani, A., Invitti, C., Dubini, A., Piccoletti, R., Bendinelli, P., Maroni, P., Pezzoli, G., Ramella, G., Calogero, A., & Cavagnini, F. (1995). Cerebrospinal fluid and plasma concentrations of SRIH, beta-endorphin, CRH, NPY, and GRRH in obese and normal weight subjects. International Journal of Obesity, 19, 17-21.
11. Bryde Andersen, H., Raben, A., Astrup, A., & Christensen, N. J. (1994). Plasma adrenaline concentration is lower in post-obese than in never-obese women in the basal state, in response to sham-feeding and after food intake. Clinical Science, 87, 69-74.
12. Cooper, S. J., Dourish, C. T., & Clifton, P. G. (1992). CCK antagonists and CCK-monoamine interactions in the control of satiety. American Journal of Clinical Nutrition, 55, 291S-295S.
13. Craighead, L. W., & Agras, W. S. (1991). Mechanisms of action in cognitive-behavioral and pharmacological interventions for obesity and bulimia nervosa. Journal of Consulting and Clinical Psychology, 59, 115-125.
14. Demitrack, M. A., Putnam, F. W., Rubinow, D. R., Pigott, T. A., Altemus, M., Krahn, D. D., & Gold, P. W. (1993). Relation of dissociative phenomena to levels of cerebrospinal fluid monoamine metabolites and beta-endorphin in patients with eating disorders: A pilot study. Psychiatry Research, 49, 1-10.
15. Fullerton, D. T., Swift, W. J., Getto, C. J., & Carlson, I. H. (1986). Plasma immunoreactive beta-endorphin in bulimics. Psychological Medicine, 16, 59-63.
16. Geracioti, T. D., Kling, M. A., Joseph-Vanderpool, J. R., Kanayama, S., Rosenthal, N. E., Gold, P. W., & Liddle, R. A. (1989). Meal-related cholecystokinin secretion in eating and affective disorders. Psychopharmacology Bulletin, 25, 444-449.
17. Geracioti, T. D., & Liddle, R. A. (1988). Impaired cholecystokinin secretion in bulimia nervosa. New England Journal of Medicine, 319, 683-688.
18. Geracioti, T. D., Liddle, R. A., Altemus, M., Demitrack, M. A., & Gold, P. W. (1992). Regulation of appetite and cholecystokinin secretion in anorexia nervosa. American Journal of Psychiatry, 149, 958-961.
19. Gerner, R. H., & Yamada, T. (1982). Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients. Brain Research, 238, 298-302.
20. Gillberg, C. (1994). Whither research in anorexia and bulimia nervosa? British Journal of Hospital Medicine, 51, 209-215.
21. Giovannini, C., Ciucci, E., Clementi, R., Cugini, P., Facchinetti, F. & Negri, M. (1990). Beta-endorphin, insulin, ACTH, and cortisol plasma levels during oral glucose tolerance test in obesity after weight loss. Hormone & Metabolite Research, 22, 96-100.
22. Giugliano, D., Cozzolino, D., Torella, R., Lefebvre, P. J., Franchimont, P., & D'Onofrio, F. (1991). Persistence of altered metabolic response to beta-endorphin after normalization of body weight in human obesity. Acta Endocrinologica, 124, 159-165.
23. Hubner, H. F. (1993). Endorphins, eating disorders, and other addictive behaviors. New York: W. W. Norton & Company.
24. James, W. P. T. (1995). A public health approach to the problem of obesity. International Journal of Obesity. 19(Suppl. 3), S37-S45.
25. Jarry, J. L., & Vaccarino, F. J. (1996). Eating disorder and obsessive-compulsive disorder: Neurochemical and phenomenological commonalities. Journal of Psychiatry & Neuroscience, 21, 36-48.
26. Jimerson, D. C. (1993). The role of central catecholamine pathways in eating disorders. In E. Ferrari, F. Brambilla, & S. B. Solerte (Eds.) Primary and secondary eating disorders: A psychoneuroendocrine and metabolic approach (pp. 59-64). Oxford. UK: Pergamon Press.
27. Jimerson, D. C., Lesem, M., Kaye, W. H., & Brewerton, T. D. (1992). Low serotonin and dopamine metabolic concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Archives of General Psychiatry, 49, 132-138.
28. Kaye, W. H. (1992). Neuropeptide abnormalities. In K. A. Halmi (Ed.), Psychobiology and treatment of anorexia nervosa and bulimia nervosa (pp. 169-191). Washington DC: American Psychiatric Press.
29. Kaye, W. H. (1993). Central nervous system neuropeptide abnormalities in anorexia and bulimia nervosa. In E. Ferrari, F. Brambilla, & S. B. Solerte (Eds.), Primary and secondary eating disorders: A psychoneuroendocrine and metabolic approach (pp. 65-73). Oxford, UK: Pergamon Press.
30. Kaye, W. H., Ballenger, J. C., Lydiard, B., Stuart, G. W., Laraia, M. T., O'Neil, P., Fossey, M. D., Stevens, V., Lesser, S., & Hsu, G. (1990a). CSF monoamine oxidase levels in normal-weight bulimia: Evidence for abnormal noradrenergic activity. American Journal of Psychiatry, 147, 225-229.
31. Kaye, W. H., Berrettini, W. H., Gwirtsman, H. E., Chretien, M., Gold, P. W., George, D. T., Jimerson, D. C., & Ebert, M. H. (1987). Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including beta-endorphin) in anorexia nervosa. Life Sciences, 41, 2147-2155.
32. Kaye, W. H., Berretini, W., Gwirtsman, H. E., & George, D. T. (1990b). Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa. Archives of General Psychiatry, 47, 548-556.
33. Kaye, W. H., Berrettini, W. H., Gwirtsman, H. E., Gold, P. W., George, D. T., Jimerson, D. C., & Ebert, M. H. (1989). Contribution of CNS neuropeptide (NPY, CRH, and beta-endorphin) alterations to psychophysiological abnormalities in anorexia nervosa. Psychopharmacology Bulletin, 25, 433-438.
34. Kaye, W. H., Gwirtsman, H. E., George, D. T., & Ebert, M. H. (1991). Altered serotonin activity in anorexia nervosa after long-term weight restoration: Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior? Archives of General Psychiatry, 48, 556-562.
35. Kaye, W. H., Pickar, D., Naber, D. & Ebert, M. H. (1982). Cerebrospinal fluid opioid activity in anorexia nervosa. American Journal of Psychiatry, 139, 643-645.
36. Kaye, W. H., & Weltzin, T. E. (1991). Neurochemistry of bulimia nervosa. Journal of Clinical Psychiatry, 52, 21-28.
37. Kaye, W. H., Weltzin, T. E., & Hsu, L. K. G. (1993). Serotonin and norepinephrine activity in anorexia and bulimia nervosa: Relationship to nutrition, feeding, and mood. In J. J. Mann & D. J. Kupfer (Eds.) Biology of depressive disorders (Part B): Subtypes depression and comorbid disorders (pp. 127-149). New York: Plenum Press.
38. Keller, M. B., Herzog, D. B., Lavori, P. W., Bradburn, I. S., & Mahoney, E. M. (1992). The naturalistic history of bulimia nervosa: Extraordinary high rates of chronicity, relapse, recurrence, and psychosocial morbidity. International Journal of Eating Disorders, 12, 1-9.
39. Kirschenbaum, D. S., & Fitzgibbon, M. L. (1995). Controversy about the treatment of obesity: Criticisms or challenges? Behavior Therapy, 26, 43-68.
40. Leibowitz, S. F. (1990). The role of serotonin in eating disorders. Drugs, 39, 33-48.
41. Lieverse, R. J., Jansen, J. B. M. J., Masclee, A. A. M., & Lamers, C. B. H. W. (1995). Satiety effects of a physiological dose of cholecystokinin in humans. Gut, 36, 176-179.
42. Lydiard, R. B., Brewerton, T. D., Fossey, M. D., Laraia, M. T., Stuart. G., Beinfeld, M. C., & Ballenger, J. C. (1993). CSF cholecystokinin octapeptide in patients with bulimia nervosa and in normal comparison subjects. American Journal of Psychiatry, 150, 1099-1101.
43. 2 dopamine receptor gene: Obesity, smoking, and mood. In S. T. St. Jeor (Ed.), Obesity Assessment: Tools, methods, interpretation. New York: Chapman & Hall.
44. 2 dopamine receptor gene and obesity. International Journal of Eating Disorders, 15, 205-217.
45. Pirke, K. M., Kellner, M. B., Frieß, E., Krieg, J.-C., & Fichter, M. M. (1994). Satiety and cholecystokinin. International Journal of Eating Disorders. 15, 63-69.
46. Pirke, K. M., Philipp, E., Frieß, E., Kellner, B., Wilckens, T., Krieg, J.-C., & Fichter, M. M. (1993). The role of gastrointestinal hormone secretion in eating disorders. In E. Ferrari, F. Brambilla, & S. B. Solerte (Eds.), Primary and secondary eating disorders: A psychoneuroendocrine and metabolic approach (pp. 75-79). Oxford, UK: Pergamon Press.
47. Pirke, K. M., Philipp, E., Schweiger, U., Broocks, A., & Wilckens, T. (1992). Neuroendocrine and reproductive function. In K. A. Halmi (Ed.), Psychobiology and treatment of anorexia nervosa and bulimia nervosa (pp. 151-167). Washington. DC: American Psychiatric Press.
48. Poston, W. S. C., & Winebarger, A. A. (1996). The misuse of behavioral genetics in prevention research or for whom the "Bell Curve" tolls. Journal of Primary Prevention, 17, 133-147.
49. Ross. C. A., & Pam, A. (1995). Pseudoscience in biological psychiatry. New York: John Wiley & Sons.
50. Scavo, D., Barletta, C., Buzetti, R., & Vagiri, D. (1988). Effects of caloric restriction and exercise on β-endorphin, ACTH, and cortisol circulating levels in obesity. Physiology & Behavior, 42, 65-68.
51. Striegel-Moore, R. H. (1995). A feminist perspective on the etiology of eating. In K. D. Brownell & C. G. Fairburn (Eds.), Eating disorders and obesity: A comprehensive handbook (pp. 224-229). New York: The Guilford Press.
52. Strober, M. (1995). Family-genetic perspectives on anorexia and bulimia nervosa. In K. D. Brownell & C. G. Fairburn (Eds.), Eating disorders and obesity: A comprehensive handbook (pp. 212-218). New York: The Guilford Press.
53. Study Group on Anorexia Nervosa. (1995). Anorexia nervosa: Directions for future research. International Journal of Eating Disorders, 17, 235-241.
54. Tepper, R., Weizman, A., Apter, A., Tyano, S., & Beyth, Y. (1992). Elevated plasma immunoreactive β-endorphin in anorexia nervosa. Clinical Neuropharmacology, 15, 387-391.
55. Vandereycken, W., & Hoek, H. W. (1992). Are eating disorders culture-bound syndromes? In K. A. Halmi (Ed.), Psychobiology and treatment of anorexia nervosa and bulimia nervosa (pp. 19-36). Washington, DC: American Psychiatric Press.
56. Weltzin, T. E., Fernstrom, M. H., & Kaye, W. H. (1994). Serotonin and bulimia nervosa. Nutrition Reviews, 52, 399-408.
57. Young, J. B., & Macdonald, I. A. (1992). Sypathoadrenal activity in human obesity: heterogeneity of findings since 1980. International Journal of Obesity, 16, 959-967.
58. Zelissen, P. M., Koppeschaar, H. P., Erkelens, D. W., & Thijssen, J. H. (1991a). Beta-endorphin and adrenocortical function in obesity. Clinical Endocrinology, 35, 369-372.
59. Zelissen, P. M., Koppeschaar, H. P., Thijssen, J. H., & Erkelens, D. W. (1991b). Beta-endorphin and insulin/glucose responses to different meals in obesity. Hormone Research, 36, 32-35.
60. Zumoff, B. (1995). Hormonal abnormalities in obesity: Cause or effect? In T. B. VanItallie, A. P. Simonpoulos, S. P. Gullo, & W. Futterweit (Eds.), Obesity: New directions in assessment and management. Philadelphia, PA: The Charles Press.